オプションチェーンは、CO2 Energy Transition Corp. - Rightの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、CO2 Energy Transition Corp. - Rightの市場センチメントを評価します。.

CO2 Energy Transition Corp. - Right (NASDAQ:NOEMR) 株価情報, オプションチェーン

CO2 Energy Transition Corp. - Right

Footwear giant Crocs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) shares were <a href="https://www.benzinga.com/premarket">trading higher in premarket</a> on Thursday after the first-quarter earnings.
The company <a href="https://www.benzinga.com/pressreleases/25/05/n45280948/crocs-inc-reports-better-than-expected-first-quarter-results-fueled-by-outperformance-in-both-croc">reported a first-quarter FY25 revenue</a> decline of 0.14% year-on-year to $937.33 million, beating the analyst consensus estimate of $907.89 million.
Adjusted EPS of $3.00 <a href="https://www.benzinga.com/earnings">beat the consensus</a> estimate of $2.48.
Crocs brand revenues grew 2.4% to $762 million, or 4.2%, on a constant currency basis. Direct-to-consumer revenues rose 1.1% to $285 million, while wholesale revenues increased 3.2% to $477 million.
HEYDUDE's total revenues decreased 9.8% to&nbsp;$176 million. Direct-to-consumer revenues grew 8.3% to&nbsp;$65 million, while wholesale revenues fell 17.9% to&nbsp;$111 million.
Also Read: <a href="https://www.benzinga.com/25/05/45237060/despite-nikes-executive-overhaul-ongoing-challenges-persist-says-analyst">Nike Revamps C-Suite, &#8216;Win Now&#8217; Strategy Faces Profit Pressure: Analyst</a>
Adjusted gross margin improved 180 basis points to 57.8% compared to 56%. Crocs reported an adjusted operating margin of 23.8% in the quarter, lower than 27.1% in the year-ago period.
In the first quarter, Crocs repurchased approximately 0.6 million shares for $61 million at the average share price of $100.23. At quarter-end, approximately $1.3 billion of share repurchase authorization remained available for future repurchases.
"We are incredibly proud of our better-than-expected first-quarter performance despite what has been an increasingly volatile macroeconomic backdrop since the onset of the year," said CEO Andrew Rees.
&#8220;While we are pleased by the performance of our overall business in April, the new global trade environment as well as business and consumer uncertainty, has made it challenging to predict how consumers may respond in the future. Amid this heightened operating backdrop, we are withdrawing our guidance for 2025,&#8221; Rees added.
As of March 31, the company's cash and cash equivalents&nbsp;were&nbsp;$166 million&nbsp;compared to&nbsp;$159 million in the year-ago period. Inventories&nbsp;were&nbsp;$391 million&nbsp;compared to&nbsp;$392 million.
Outlook: Due to macroeconomic uncertainties stemming from global trade policies, Crocs is withdrawing its full-year 2025 financial outlook, which was provided on February 13, 2025.
Price Action: CROX shares traded higher by 3.13% at $103.92 in premarket at last check Thursday.
Read Next: <a href="https://www.benzinga.com/25/05/45272097/kellogg-has-margin-opportunity-but-challenges-keep-shares-grounded-says-analyst">Long-Term Decline In Cereal Market Poses Structural Challenges For Kellogg, Analyst Says</a>
Photo: Shutterstock

Earnings

News

General

CROX

Why Is Footwear Giant Crocs Stock Surging Today?

Trading Ideas

ASST

Asset Entities Shares Resume Trade Following Circuit Breaker Halt

WIIM

AXON

Axon Enterprise shares are trading higher after the company reported better-than-expected Q1 financial results and raised FY25 sales guidance.

Takeda Pharmaceutical Company Limited&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAK#NYSE">TAK</a>) reported&nbsp;a fiscal year 2024 net profit of 107.9 billion yen (around $709.86 million),&nbsp;down <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45276827/takeda-announces-fy2024-full-year-results-and-fy2025-outlook-reflecting-growth-launch-products-mom" rel="noreferrer noopener">25.1% year over year</a>.
Core net profit increased 2.5% (down 3.4% at constant currency) to 775.6 billion yen.
Takeda CEO Christophe Weber said, "Takeda delivered excellent results in FY2024. Our return to Core Operating Profit margin growth underscores the strength of our Growth &amp; Launch Products portfolio and the ability of our multi-year efficiency program to deliver meaningful cost savings.
Revenue was 4.26 trillion yen (around $28.4 billion), up 7.5% (or up 29% at constant currency).
<ul>
<li>The increase is attributable to favorable foreign exchange rates and growth from business momentum of Gastroenterology (GI), Rare Diseases, Plasma-Derived Therapies (PDT), Oncology, and Vaccines, partly offset by a decrease in Neuroscience.</li>
</ul>
Takeda reported the fiscal year 2024 operating profit of 342.6 billion yen, up 60%, and core operating profit of 1.162 trillion yen, up 10.2% (up 4.9% on constant currency).
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44084427/takeda-protagonist-therapeutics-partnered-investigational-drug-hits-primary-goal-in-late-stage-study-in-patients-with-type-of-blood-cancer" rel="noreferrer noopener">Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer</a>
Takeda expects the potential exposure to U.S. and China tariffs to be limited. It <a target="_blank" href="https://assets-dam.takeda.com/image/upload/v1746669209/Global/Investor/Financial-Results/FY2024/Q4/qr2024_q4_p01_en.pdf" rel="noreferrer noopener">notes</a>:
<ul>
<li>50% of the total Takeda revenue is from the U.S.</li>
<li>The value of imports (primarily from Europe/Japan/Singapore) is around 8 to 10% of total U.S. revenue.</li>
<li>Around 4% of the total Takeda revenue is from China.</li>
<li>The value of imports (from the U.S.) is around 12% to 15% of total China revenue.</li>
<li>Takeda said it is taking mitigation measures (e.g., inventory and supply chain management) for imports that may be subject to potential tariff impacts.</li>
</ul>
Guidance:&nbsp;Takeda forecasts its operating profit will reach 475 billion yen in the fiscal year 2025, broadly flat year over year on a constant currency basis.
The company expects revenues of 4.53 trillion yen, reported earnings per share of 145 yen, and core earnings of 485 yen per share.
"FY2025 will be a pivotal year as we invest in launch readiness for the late-stage pipeline, which will contribute to our broadly flat Core Operating Profit outlook for FY2025 but will be key to achieving Takeda's long-term growth potential," Weber said.
Price Action: TAK stock is down 5.2% at $14.26 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/05/45284262/exxon-mobil-says-deal-with-japans-marubeni-to-boost-jobs-global-energy-supply" target="_blank" rel="noreferrer noopener">Exxon Mobil Says Deal With Japan&#8217;s Marubeni To Boost Global Energy Supply</a></li>
</ul>
Photo: Gorodenkoff/Shutterstock

Biotech

Large Cap

Guidance

Health Care

Movers

Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs

Guggenheim analyst John Heinbockel maintains Dollar General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Buy and raises the price target from $100 to $105.

Price Target

Analyst Ratings

Guggenheim Maintains Buy on Dollar General, Raises Price Target to $105

Scotiabank analyst Phil Hardie maintains Intact Financial (TSX:<a class="ticker" href="https://www.benzinga.com/stock/IFC#TSX">IFC</a>) with a Sector Outperform and raises the price target from C$298 to C$305.

TSX:IFC

Scotiabank Maintains Sector Outperform on Intact Financial, Raises Price Target to C$305

PPG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) today announced that it will invest $380 million to build a new aerospace coatings and sealants manufacturing facility in Shelby, N.C. Construction on the 62-acre site, which will initially include manufacturing and warehousing units, is set to commence in October 2025 and is expected to be completed in the first half of 2027.
The 198,000-square-foot facility will enable the company to continue meeting the growing demands of the aerospace industry. It will employ more than 110 people and produce the full line of PPG's aerospace coatings and sealants. The additional capacity of this new plant, combined with nearby transport links that improve supply chain and shipping logistics, will help improve service levels for customers.

PPG To Invest $380M To Build New Aerospace Coatings And Sealants Manufacturing Facility In Shelby

Oppenheimer analyst Noah Kaye maintains Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) with a Outperform and raises the price target from $90 to $96.

Oppenheimer Maintains Outperform on Johnson Controls Intl, Raises Price Target to $96

Macro Economic Events

Econ #s

Economics

USA Natural Gas Storage 104B Vs 103B Est.; 107B Prior

Scotiabank analyst Patrick Colville maintains Informatica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFA#NYSE">INFA</a>) with a Sector Perform and raises the price target from $18 to $19.

INFA

Scotiabank Maintains Sector Perform on Informatica, Raises Price Target to $19

Guggenheim analyst Gregory Francfort maintains First Watch Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) with a Buy and lowers the price target from $23 to $22.

FWRG

Guggenheim Maintains Buy on First Watch Restaurant Gr, Lowers Price Target to $22

Paycom Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) reported better-than-expected earnings for the <a href="https://www.benzinga.com/quote/PAYC/earnings">first quarter on Wednesday</a>.
The company posted quarterly earnings of $2.80 per share which beat the analyst consensus estimate of $2.56 per share. The company reported quarterly sales of $530.50 million which beat the analyst consensus estimate of $524.95 million.
&#8220;We delivered strong results in the first quarter, led by our differentiated approach to automation, strong sales execution and operational efficiency gains,&#8221; said Paycom founder, CEO and chairman, Chad Richison. &#8220;Our investments in automation, client ROI achievement and world-class service are paying off. With our accelerating momentum and expanding margins, I am pleased to be able to raise our outlook for 2025.&#8221;
Paycom Software raised its FY2025 sales outlook from $2.02 billion-$2.04 billion to $2.02 billion-$2.04 billion.
Paycom Software shares gained 6.6% to trade at $243.83 on Thursday.
These analysts made changes to their price targets on Paycom Software following earnings announcement.
<ul>
<li>Piper Sandler analyst Arvind Ramnani maintained Paycom Software with a Neutral and raised the price target from $224 to $246.</li>
<li>Stifel analyst Brad Reback maintained the stock with a Hold and raised the price target from $187 to $215.</li>
<li>Needham analyst Joshua Reilly, meanwhile, reiterated Paycom Software with a Hold rating.</li>
</ul>
Considering buying PAYC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="570" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08102607/image-87-1024x570.png" alt="" class="wp-image-908189" style="width:585px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08102607/image-87-1024x570.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08102607/image-87-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08102607/image-87-768x428.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08102607/image-87.png 1077w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45284390/how-to-earn-500-a-month-from-mckesson-stock-ahead-of-q4-earnings">How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings</a> </li>
</ul>
Photo via Shutterstock

Markets

PAYC

Paycom Software Analysts Boost Their Forecasts After Better-Than-Expected Results

Bitcoin crossed the $100,000 threshold for the first time since February on Thursday before slipping slightly to $99,469—<a href="https://www.benzinga.com/money/how-to-buy-bitcoin-btc-best-bonuses-august-2024#:~:text=Users%20need%20to%20set%20up,bank%20transfers%2C%20and%20other%20cryptocurrencies.">still up 2.6% on the day and 3.06% for the week</a>. The rally adds to a 24.2% gain over the past month and reflects growing investor confidence in the asset amid major geopolitical and monetary shifts.
Markets responded enthusiastically to U.S. President Donald Trump's social media announcement of a &#8220;major trade deal&#8221; with the U.K. in the works, fueling optimism that the U.S. trade war could ease. Treasury Secretary Scott Bessent is expected to meet with Chinese officials in Switzerland, marking the first bilateral trade talks since the Trump administration's renewed tariff measures.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto? <a href="http://coinbase-consumer.sjv.io/m5ALXy">Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
</ul>
In tandem, institutional appetite continues to surge. U.S.-listed spot Bitcoin ETFs saw $142 million in net inflows Wednesday, reversing Tuesday's $85 million in outflows. Ark Invest's ARKB led the charge, attracting $54.7 million alone. According to Farside Investors, cumulative inflows into U.S.-based Bitcoin ETFs have now surpassed $40.6 billion.
Standard Chartered analyst Geoff Kendrick doubled down on his bullish forecast, sharing with Decrypt Thursday that his Q2 price target of $120,000 may be too conservative. He cited institutional disclosures due next week and strong macro support.&nbsp;
Federal Reserve Chair Jerome Powell's policy comments also lifted risk-on sentiment. On Wednesday, the Fed left interest rates unchanged at 4.5%, while Powell emphasized a &#8220;solid&#8221; U.S. economic position despite heightened uncertainty from tariffs and global trade disruptions.
Marco Lim of MaiCapital told Decrypt that if the Fed follows through with its projected rate cuts, Bitcoin could not only retest $100,000 but break out toward Kendrick's target.&nbsp;
The sentiment is mirrored in investor behavior. The Crypto Fear and Greed Index climbed to 65—firmly in Greed territory—up from Neutral last week. On decentralized prediction platform Myriad, 91% of participants expect the index to remain elevated through Friday.
Adding fuel to the bullish thesis, Arizona passed legislation allowing the state to invest in Bitcoin and take ownership of dormant coins. It marks the second U.S. state to endorse a similar measure, signaling growing domestic acceptance of Bitcoin as a treasury asset.
More Opportunities:
<ul>
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Bitcoin Taps $100,000 As Trump Trade Talks And Fed Policy Fuel Bullish Sentiment

Oppenheimer analyst Jeff Jones maintains Immunocore Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) with a Outperform and raises the price target from $85 to $86.

IMCR

Oppenheimer Maintains Outperform on Immunocore Holdings, Raises Price Target to $86

Scotiabank analyst Robert Hope maintains Fortis (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FTS#TSX">FTS</a>) with a Sector Perform and raises the price target from C$66 to C$70.

TSX:FTS

Scotiabank Maintains Sector Perform on Fortis, Raises Price Target to C$70

Guggenheim analyst Debjit Chattopadhyay maintains Soleno Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNO#NASDAQ">SLNO</a>) with a Buy and raises the price target from $81 to $97.

SLNO

Guggenheim Maintains Buy on Soleno Therapeutics, Raises Price Target to $97

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is pushing toward the $100,000 mark once again, with analysts forecasting a potential breakout to $112,000 and beyond, while warning that altcoins remain structurally weak amid rising dominance and <a href="https://www.benzinga.com/money/bitcoin-price-prediction">macro shifts favoring BTC.</a>
What Happened: At the time of writing, Bitcoin trades at $99,350, up 2.5% in the last 24 hours after hitting a session high of $99,868.
The broader crypto market is showing signs of bullishness, with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) climbing 7.5% to $1,965, Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) up 5.4%, BNB (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>) gaining 1% and XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) rising 4%.
Still, the divergence between Bitcoin and altcoins remains stark.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45281333/bitcoin-120000-price-target-may-be-too-low-says-standard-chartered-i-apologize">Bitcoin $120,000 Price Target May Be Too Low, Says Standard Chartered: &#8216;I Apologize&#8217;</a>
What Experts Are Saying: According to Nic Puckrin, analyst and founder of The Coin Bureau, Bitcoin&#8217;s current momentum is driven more by geopolitical developments than monetary policy.
"Markets this morning are reacting to President Donald Trump's hint at a major UK trade deal, not Fed policy," he said. "If the announcement is concrete, today could be the day BTC cracks $100,000 again."
Puckrin added a note of caution for short-term traders. "BTC is rallying on low volume, and if Trump's announcement lacks specifics, we could see volatility spike."
Longer term, however, Puckrin remains optimistic. "ETF inflows remain strong, and legislative momentum like reserve bills in New Hampshire and Arizona, continues to build. Add to that China's recent liquidity moves, and it's shaping up to be a very strong month for Bitcoin."
Technical signals also point to more upside. 
FxPro's chief market analyst Alex Kuptsikevich noted that the crypto market has broken above its 200-day moving average and now targets $3.2 trillion in total market cap. 
"Bitcoin reaching $99,000 sets up a Fibonacci extension that could push it past $112,000, with broader upside aiming toward $162,000," he said.
That bullishness stands in stark contrast to the altcoin sector, which has been heavily under pressure. 
What&#8217;s Next: According to a new report from 10x Research, the top 140 altcoins are down an average of 58% since their December 2024 peak, while Bitcoin has dropped just 3% over the same period.
The divergence, analysts say, is explained by a mix of supply gluts and lackluster narratives. 
"$57 billion in annual token unlocks have overwhelmed demand," the report notes. "With venture capital tightening and no breakout use case, altcoins are stuck in a structural downtrend."
As a result, Bitcoin dominance has surged to 64.5%, the highest since ETF approvals began, while Ethereum gas fees have fallen from 16 Gwei to just 3 Gwei, highlighting collapsed on-chain activity. 
Even as major altcoins show modest daily gains, their cumulative performance paints a more fragile picture.
Meanwhile, $376 million in liquidations over the past 24 hours, $86 million in longs and $290 million in shorts, suggest ongoing volatility as traders adjust to the new market structure.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/05/45274548/anthony-scaramucci-gives-donald-trump-b-or-a-on-crypto-but-warns-presidential-meme-coin-defi-project">Anthony Scaramucci Gives Donald Trump &#8216;B+ Or A-&#8216; On Crypto But Warns Presidential Meme Coin, DeFi Project Risk Derailing Policy Progress</a></li>
</ul>
Image: Shutterstock

$BNB

$BTC

$ETH

$SOL

$XRP

Bitcoin, Ethereum, XRP Surge As Experts Predict BTC To $112,000 Soon

Oppenheimer analyst Owen Lau maintains Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) with a Outperform and raises the price target from $2116 to $2293.

FICO

Oppenheimer Maintains Outperform on Fair Isaac, Raises Price Target to $2293

Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) just clocked one of its worst trading days since 2023, shedding over 7% and nearly <a href="https://www.benzinga.com/quote/GOOGL">$150 billion in market cap</a>.
<h2 class="wp-block-heading">Apple Exec&#8217;s Testimony Sends Google Stock Plummeting</h2>
What caused the market to pull the plug? A courtroom mic-drop from Apple Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) Eddy Cue, senior VP of Internet software and services.
Cue's testimony at the Google Commercial Search antitrust trial sent shockwaves through the tech world. He revealed that Apple saw its first drop in search volume in two decades this April &#8211; and pointed the finger squarely at AI rivals like ChatGPT and Perplexity.
More alarming, Apple has been chatting with both about becoming potential Safari search partners. That's like inviting your ex's nemesis to the prom.
Read Also: <a href="https://www.benzinga.com/markets/equities/25/05/45277969/ai-is-eating-search-google-rival-perplexity-ceo-arvind-srinivas-says-as-dan-nile-predicts-agents-to-take-future-share-amid-alphabet-apple-stock-fall">&#8216;AI Is Eating Search&#8217; Google Rival Perplexity CEO Arvind Srinivas Says As Dan Niles Predicts &#8216;Agents&#8217; To Take Future Share Amid Alphabet, Apple Stock Fall</a>
<h2 class="wp-block-heading">Google Stock Sell-Off Overdone, Says Analyst</h2>
Investors didn't take it lightly. Google's dominance in search suddenly looked a bit shakier, especially with paid click growth crawling at just 2% in Q1 &#8211; down from mid-single digits last year. But JPMorgan analyst Doug Anmuth thinks the sell-off was a bit much. In his words: "Overdone."
Anmuth emphasized that Google is still the default on Safari and continues to see "overall query growth&#8230;including coming from Apple devices." He also notes that Apple&#8217;s $20 billion revenue share from Google is too big to walk away from.
While <a href="https://www.benzinga.com/quote/GOOGL/analyst-ratings">bears highlight a</a> slowing growth story, bulls point to Google&#8217;s fundamentals. YouTube&#8216;s ad revenue climbed 14% in the fourth quarter of 2024 and Google Services&#8217; operating margin jumped to a strong 39%. Not to mention, AI Overviews now reaches 1.5 billion users monthly—a stat worth bragging about as the I/O event looms on May 20.
With Google stock trading at just 16.1x forward earnings, according to data from <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0508">Benzinga Pro</a> &#8211; 42% below the S&amp;P 500's <a href="https://worldperatio.com/index/sp-500/">27.65x</a> &#8211; and Wall Street&#8217;s top analysts pegging a 44.6% upside, there's a case to be made that this panic is more courtroom drama than structural decline.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45282981/top-3-health-care-stocks-that-could-sink-your-portfolio-in-q2">Top 3 Health Care Stocks That Could Sink Your Portfolio In Q2</a></li>
</ul>
Google: Shutterstock

Analyst Color

Long Ideas

Tech

AAPL

GOOG

GOOGL

Google At Staggering 42% Discount To S&P 500 After $150 Billion Value Dive

Scotiabank analyst Patrick Colville maintains Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) with a Sector Outperform and lowers the price target from $135 to $115.

Comments

CO2 Energy Transition Corp. - Right

CO2 Energy Transition Corp. - Right (NOEMR) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル